• Archit Organosys board meeting scheduled for May 16, 2026 to approve audited financial results for Q4 and FY ending March 31, 2026.
• Trading window closed from April 1, 2026 for insiders including promoters, directors, and senior management personnel.
• Window will reopen 48 hours after financial results become generally available to the public.
• Disclosure made to BSE Limited in compliance with SEBI listing regulations and insider trading norms.